NASDAQ
CME
Last Price
US $269.80
KEY FIGURES
MKT CAP
$97.0B
EPS
TTM
$11.87
PEG
TTM
1.54x
P/E
TTM
22.74x
P/S
TTM
14.34x
YIELD
4.17%
GROWTH
Revenue Y/Y
5.95%
(FY vs FY)
EBITDA Y/Y
Cash Flow (DCF)
Fair Value
Market $269.80
-23.27%
Default assumptions
EBITDA Multiple
Fair Value
Market $269.80
-58.41%
Default assumptions
Valuation
Financial
Performance
Financial stability - Cash flow debt coverage.
CME Group Inc. cash flow to debt ratio of 113.84% indicates that the company generates enough cash to cover a substantial portion of its debt. This level indicates very strong financial health.
Financial stability - Healthy cash flow growth.
CME Group Inc.'s free cash flow has increased 16.60% from $3.60G last year to $4.19G, signaling increasing performance
Financial stability - Healthy debt to equity ratio.
CME Group Inc.'s debt to equity ratio is 0.13, which means that the company's assets are healthy financed, signaling financial stability. READ MORE: A ratio under 0.60 means the company finances its assets with own equity, signaling financial stability and good management.
Financial risk - Healthy debt to equity ratio development.
CME Group Inc.'s debt has increased relative to shareholder equity from 0.13 last year to 0.13 today, signaling weakened financials
Financial stability - Net debt/EBITDA.
CME Group Inc. has a net debt to EBITDA ratio of 0.00x, which is below the 3.00x threshold, indicating healthy leverage and financial stability
Financial stability - ICR.
CME Group Inc.'s interest coverage ratio of 50.27 indicates that earnings with good margin can cover interest payments on company debt
Financial stability - Profit margin growth.
CME Group Inc.'s profit margin has increased (9.67%) in the last year from 57.52% to 63.08%, signaling increasing performance
Financial stability - Short term assets vs short term liabilities.
CME Group Inc.'s short-term assets of $5.19G exceed its short-term liabilities of $55.80M
Decreasing performance - ROA.
CME Group Inc.'s return on assets of 2.19% is lower than the 5.00% threshold, indicating inefficient asset utilization
Increasing performance - Absolute return on equity.
CME Group Inc.'s return on equity of 15.53%, is higher than 15.00%, indicating good performance
Increasing performance - Earnings quality.
CME Group Inc.'s operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation
Increasing performance - Earnings stability.
CME Group Inc. had positive net income in 5.00 out of 5 years, indicating stable and consistent earnings
Increasing performance - Free cash flow.
CME Group Inc. has positive free cash flow, indicating the company generates cash after capital expenditures
Increasing performance - FCF yield.
CME Group Inc. has a free cash flow yield of 4.32%, which is above the 2.00% threshold, indicating strong cash generation relative to market value
Increasing performance - Healthy earnings growth.
CME Group Inc.'s yearly earnings has increased 14.71% since last year from $3.53G to $4.04G, signaling increasing performance
Increasing performance - Healthy revenue growth.
CME Group Inc.'s yearly revenue has increased 6.37% since last year from $6.13G to $6.52G, signaling increasing performance
Increasing performance - ROIC.
ROIC 9.38% (Source: FMP key-metrics). In the 5–10% partial-credit band. Score: 1 of 2. This band sits within the typical US weighted-average cost of capital range. Methodology choice can change the conclusion: under FMP's invested-capital definition the company is at or near its cost of capital; under narrower operating-capital definitions the same company may score higher. Invested capital here includes equity, non-current liabilities, and short-term debt. Cash is not subtracted. See methodology.
Increasing performance - 3-year revenue CAGR.
CME Group Inc.'s 3-year revenue CAGR of 9.11% is positive, indicating growing revenue over the past 3 years
Increasing performance - Revenue consistency.
CME Group Inc. had revenue growth in 4.00 out of 5 years, indicating consistent revenue performance
Increasing performance - ROE consistency.
CME Group Inc. had positive ROE in 5.00 out of 5 years, indicating consistent and reliable returns on equity
Overvalued - DCF valuation.
CME Group Inc. is overvalued relative to its fair value price of 207.01 based on Discounted Cash Flow model
Undervalued - Earnings yield.
CME Group Inc. has an earnings yield of 4.40%, which is above the 4.00% threshold, indicating the stock offers reasonable value relative to its earnings
Overvalued - EBITDA valuation.
CME Group Inc. is overvalued relative to its fair value price of 112.21 based on EBITDA multiple model
Undervalued - EV/EBITDA.
CME Group Inc. has an EV/EBITDA ratio of 16.84x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings
Overvalued - PEG ratio value.
CME Group Inc. has a PEG-ratio over 1 which is considered overvalued
Undervalued - P/B ratio.
CME Group Inc. has a price-to-book ratio of 3.67x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Overvalued - P/S ratio.
CME Group Inc. has a price-to-sales ratio of 14.34x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue
Profit margin
Current Ratio
Capital Returns
15.53%
Return on equity
ROIC: 9.38%
Valuation History
22.3X
Price to Earnings
EV/EBITDA: 18.3X
Cash flow
Profit margin
11.28%
(FY vs FY)
Cash flow Y/Y
10.74%
(FY vs FY)
Base valuations use default assumptions. Customize in the Valuator.